{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:14:02Z","timestamp":1780881242429,"version":"3.54.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Macular fibrosis is an end-stage complication of neovascular Age-related Macular Degeneration (nAMD) with a complex and multifactorial pathophysiology that can lead to significant visual impairment. Despite the success of anti-vascular endothelium growth factors (anti-VEGF) over the last decade that revolutionised the management and visual prognosis of nAMD, macular fibrosis develops in a significant proportion of patients and, along with macular atrophy (MA), is a main driver of long-term vision deterioration. There remains an unmet need to better understand macular fibrosis and develop anti-fibrotic therapies. The use of imaging biomarkers in combination with novel Artificial Intelligence (AI) algorithms holds significant potential for improving the accuracy of diagnosis, disease monitoring, and therapeutic discovery for macular fibrosis. In this review, we aim to provide a comprehensive overview of the current state of knowledge regarding the various imaging modalities and biomarkers for macular fibrosis alongside outlining potential avenues for AI applications. We discuss manifestations of macular fibrosis and its precursors with diagnostic and prognostic significance on various imaging modalities, including Optical Coherence Tomography (OCT), Colour Fundus Photography (CFP), Fluorescein Angiography (FA), OCT-Angiography (OCTA) and collate data from prospective and retrospective research on known biomarkers. The predominant role of OCT for biomarker identification is highlighted. The review coincides with a resurgence of intense research interest in academia and industry for therapeutic discovery and clinical testing of anti-fibrotic molecules.<\/jats:p>","DOI":"10.1007\/s00417-025-06790-0","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T20:58:26Z","timestamp":1741553906000},"page":"1789-1800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Imaging biomarkers and artificial intelligence for diagnosis, prediction, and therapy of macular fibrosis in age-related macular degeneration: Narrative review and future directions"],"prefix":"10.1007","volume":"263","author":[{"given":"Rishikesh","family":"Gandhewar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Pontikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Moghul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Empeslidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-6277","authenticated-orcid":false,"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"12","key":"6790_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR et al (2017) Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health 5(12):e1221\u2013e1234","journal-title":"Lancet Glob Health"},{"issue":"2","key":"6790_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106\u2013e116","journal-title":"Lancet Glob Health"},{"issue":"14","key":"6790_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419\u20131431","journal-title":"N Engl J Med"},{"key":"6790_CR4","first-page":"1849","volume":"7","author":"JLA Rakic","year":"2013","unstructured":"Rakic JLA, Bri\u00e9 H, Denhaerynck K, Pacheco C, Vancayzeele S, Hermans C, MacDonald K, Abraham I (2013) Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study. Clin Ophthalmol 7:1849\u20131858","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"6790_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 116(1):57-65.e5","journal-title":"Ophthalmology"},{"issue":"12","key":"6790_CR6","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(12):2537\u20132548","journal-title":"Ophthalmology"},{"issue":"9","key":"6790_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/IAE.0000000000000548","volume":"35","author":"EH Souied","year":"2015","unstructured":"Souied EH, Oubraham H, Mimoun G, Cohen SY, Quere S, Derveloy A (2015) Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice. Retina 35(9):1743\u20131749","journal-title":"Retina"},{"issue":"10","key":"6790_CR8","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41433-020-0764-9","volume":"34","author":"S Chandra","year":"2020","unstructured":"Chandra S et al (2020) Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration. Eye 34(10):1888\u20131896","journal-title":"Eye"},{"issue":"5","key":"6790_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ceo.13742","volume":"48","author":"B Wolff","year":"2020","unstructured":"Wolff B et al (2020) Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: a single-centre French study. Clin Experiment Ophthalmol 48(5):636\u2013643","journal-title":"Clin Experiment Ophthalmol"},{"issue":"12","key":"6790_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","volume":"3","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG et al (2019) The evolution of fibrosis and atrophy and their relationship with visual outcomes in asian persons with neovascular age-related macular degeneration. Ophthalmol Retina 3(12):1045\u20131055","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"6790_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1167\/iovs.18-25189","volume":"60","author":"PK Roberts","year":"2019","unstructured":"Roberts PK et al (2019) Identification and quantification of the angiofibrotic switch in neovascular AMD. Invest Ophthalmol Vis Sci 60(1):304\u2013311","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6790_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","volume":"142","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa K, Kannan R, Hinton DR (2016) Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res 142:19\u201325","journal-title":"Exp Eye Res"},{"issue":"10","key":"6790_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/IAE.0000000000000583","volume":"35","author":"LA Toth","year":"2015","unstructured":"Toth LA, Stevenson M, Chakravarthy U (2015) Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Retina 35(10):1957\u20131963","journal-title":"Retina"},{"issue":"1","key":"6790_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2013.02.012","volume":"156","author":"SB Bloch","year":"2013","unstructured":"Bloch SB et al (2013) Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal Ranibizumab. Am J Ophthalmol 156(1):116-124.e1","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"6790_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","volume":"387","author":"L Tenbrock","year":"2022","unstructured":"Tenbrock L et al (2022) Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives. Cell Tissue Res 387(3):361\u2013375","journal-title":"Cell Tissue Res"},{"issue":"3","key":"6790_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","volume":"121","author":"E Daniel","year":"2014","unstructured":"Daniel E et al (2014) Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121(3):656\u2013666","journal-title":"Ophthalmology"},{"issue":"8","key":"6790_CR17","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/IAE.0b013e318240a516","volume":"32","author":"SY Cohen","year":"2012","unstructured":"Cohen SY et al (2012) Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings. Retina 32(8):1480\u20131485","journal-title":"Retina"},{"key":"6790_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","volume":"125","author":"E Daniel","year":"2018","unstructured":"Daniel E et al (2018) Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology 125:1037\u20131046","journal-title":"Ophthalmology"},{"issue":"3","key":"6790_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/ICU.0000000000000746","volume":"32","author":"R Mahmoudzadeh","year":"2021","unstructured":"Mahmoudzadeh R et al (2021) Emerging treatments for geographic atrophy in age-related macular degeneration. Curr Opin Ophthalmol 32(3):294\u2013300","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"6790_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10(1):1\u201313","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"6790_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41598-021-03716-8","volume":"12","author":"PK Roberts","year":"2022","unstructured":"Roberts PK et al (2022) Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration. Sci Rep 12(1):88","journal-title":"Sci Rep"},{"key":"6790_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","volume":"50","author":"U Schmidt-Erfurth","year":"2016","unstructured":"Schmidt-Erfurth U, Waldstein SM (2016) A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 50:1\u201324","journal-title":"Prog Retin Eye Res"},{"issue":"14","key":"6790_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.10.14.1","volume":"10","author":"PK Roberts","year":"2021","unstructured":"Roberts PK et al (2021) Morphologic and microvascular differences between macular neovascularization with and without subretinal fibrosis. Transl Vision Sci Technol 10(14):1\u20131","journal-title":"Transl Vision Sci Technol"},{"issue":"9","key":"6790_CR24","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","volume":"122","author":"AS Willoughby","year":"2015","unstructured":"Willoughby AS et al (2015) Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(9):1846-1853.e5","journal-title":"Ophthalmology"},{"issue":"11","key":"6790_CR25","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1167\/iovs.08-1877","volume":"49","author":"S Liakopoulos","year":"2008","unstructured":"Liakopoulos S et al (2008) Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49(11):5048\u20135054","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"6790_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/IAE.0b013e31820a68cc","volume":"31","author":"A Giani","year":"2011","unstructured":"Giani A et al (2011) Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography. Retina 31(5):942\u2013948","journal-title":"Retina"},{"issue":"7","key":"6790_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/IAE.0000000000000166","volume":"34","author":"VP Shah","year":"2014","unstructured":"Shah VP et al (2014) Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina 34(7):1281\u20131288","journal-title":"Retina"},{"issue":"2","key":"6790_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajo.2014.04.025","volume":"158","author":"R Ores","year":"2014","unstructured":"Ores R et al (2014) Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol 158(2):354\u2013361","journal-title":"Am J Ophthalmol"},{"key":"6790_CR29","unstructured":"Garcia-Layana A et al (2017) Optical coherence tomography in age-related macular degeneration | www.amdbook.org.\u00a0Accessed 21 Jan 2025"},{"key":"6790_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","volume":"124","author":"FG Holz","year":"2017","unstructured":"Holz FG et al (2017) Imaging protocols in clinical studies in advanced age-related macular degeneration recommendations from classification of atrophy consensus meetings. Ophthalmology 124:464\u2013478","journal-title":"Ophthalmology"},{"issue":"11","key":"6790_CR31","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/IAE.0000000000000819","volume":"35","author":"A Miere","year":"2015","unstructured":"Miere A et al (2015) Optical coherence tomography angiography features of subretinal fibrosis in age-related macular degeneration. Retina 35(11):2275\u20132284","journal-title":"Retina"},{"issue":"5","key":"6790_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/jcm9051329","volume":"9","author":"C Farinha","year":"2020","unstructured":"Farinha C et al (2020) Age-related macular degeneration staging by color fundus photography vs multimodal imaging\u2014epidemiological implications (The Coimbra Eye Study\u2014Report 6). J Clin Med 9(5):1329\u20131329","journal-title":"J Clin Med"},{"key":"6790_CR33","doi-asserted-by":"publisher","first-page":"108882","DOI":"10.1016\/j.exer.2021.108882","volume":"214","author":"L Chen","year":"2022","unstructured":"Chen L et al (2022) Histology and clinical imaging lifecycle of black pigment in fibrosis secondary to neovascular age-related macular degeneration. Exp Eye Res 214:108882\u2013108882","journal-title":"Exp Eye Res"},{"key":"6790_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7521478","volume":"2016","author":"J Gong","year":"2016","unstructured":"Gong J et al (2016) The diagnostic accuracy of optical coherence tomography angiography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography. J Ophthalmol 2016:1\u20138","journal-title":"J Ophthalmol"},{"issue":"5","key":"6790_CR35","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/eye.2015.44","volume":"29","author":"C Wilde","year":"2015","unstructured":"Wilde C et al (2015) The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography. Eye 29(5):602\u2013610","journal-title":"Eye"},{"issue":"2","key":"6790_CR36","first-page":"478","volume":"38","author":"A Von Ruckmann","year":"1997","unstructured":"Von Ruckmann A, Fitzke FW, Bird AC (1997) Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 38(2):478\u2013486","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5035","key":"6790_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D et al (1991) Optical coherence tomography. Science 254(5035):1178\u20131181","journal-title":"Science"},{"issue":"1","key":"6790_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-36704-6","volume":"9","author":"TT Lai","year":"2019","unstructured":"Lai TT et al (2019) Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study. Sci Rep 9(1):1\u201310","journal-title":"Sci Rep"},{"key":"6790_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajo.2020.11.002","volume":"223","author":"AP Finn","year":"2021","unstructured":"Finn AP et al (2021) Localized optical coherence tomography precursors of macular atrophy and fibrotic scar in the comparison of age-related macular degeneration treatments trials. Am J Ophthalmol 223:338\u2013347","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"6790_CR40","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1167\/iovs.10-6617","volume":"52","author":"A Giani","year":"2011","unstructured":"Giani A et al (2011) Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. Invest Ophthalmol Vis Sci 52(8):5579\u20135586","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"6790_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/17469899.2020.1745062","volume":"15","author":"G Casalino","year":"2020","unstructured":"Casalino G et al (2020) Hyperreflective material as a biomarker in neovascular age-related macular degeneration. Exp Rev Ophthalmol 15(2):83\u201391. https:\/\/doi.org\/10.1080\/17469899.2020.1745062","journal-title":"Exp Rev Ophthalmol"},{"issue":"6","key":"6790_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/IAE.0000000000002531","volume":"40","author":"X Hu","year":"2020","unstructured":"Hu X et al (2020) Morphological and functional characteristics at the onset of exudative conversion in age-related macular degeneration. Retina 40(6):1070\u20131078","journal-title":"Retina"},{"issue":"12","key":"6790_CR43","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.ophtha.2008.08.016","volume":"115","author":"PA Keane","year":"2008","unstructured":"Keane PA et al (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115(12):2206\u20132214","journal-title":"Ophthalmology"},{"key":"6790_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9994098","volume":"2021","author":"C Metrangolo","year":"2021","unstructured":"Metrangolo C et al (2021) OCT biomarkers in neovascular age-related macular degeneration: a narrative review. J Ophthalmol 2021:1\u201316","journal-title":"J Ophthalmol"},{"issue":"5","key":"6790_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","volume":"2","author":"G Casalino","year":"2018","unstructured":"Casalino G et al (2018) Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study. Ophthalmol Retina 2(5):451\u2013461","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"6790_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3928\/23258160-20150521-03","volume":"46","author":"W Charafeddin","year":"2015","unstructured":"Charafeddin W et al (2015) Relationship between subretinal hyperreflective material reflectivity and volume in patients with neovascular age-related macular degeneration following anti-vascular endothelial growth factor treatment. Ophthalmic Surg Lasers Imaging Retina 46(5):523\u2013530","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"6790_CR47","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1167\/iovs.15-18753","volume":"57","author":"G Casalino","year":"2016","unstructured":"Casalino G, Bandello F, Chakravarthy U (2016) Changes in neovascular lesion hyperreflectivity after anti-VEGF treatment in age-related macular degeneration: an integrated multimodal imaging analysis. Invest Ophthalmol Vis Sci 57(9):288\u2013298","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6790_CR48","doi-asserted-by":"publisher","first-page":"6648191","DOI":"10.1155\/2021\/6648191","volume":"2021","author":"J Wu","year":"2021","unstructured":"Wu J et al (2021) Imaging hyperreflective foci as an inflammatory biomarker after anti-VEGF treatment in neovascular age-related macular degeneration patients with optical coherence tomography angiography. BioMed Res Int 2021:6648191","journal-title":"BioMed Res Int"},{"issue":"11","key":"6790_CR49","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.oret.2023.06.024","volume":"7","author":"S Yu","year":"2023","unstructured":"Yu S et al (2023) Hyperreflective material boundary remodeling in neovascular age-related macular degeneration: a post hoc analysis of the AVENUE trial. Ophthalmol Retina 7(11):990\u2013998","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"6790_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcjo.2024.05.007","volume":"60","author":"S Lindenberg","year":"2025","unstructured":"Lindenberg S, Muneeswar GN, Verma N et al (2025) Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degeneration. Can J Ophthalmol 60(1):26\u201334","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"6790_CR51","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ajo.2015.02.020","volume":"159","author":"C Sch\u00fctze","year":"2015","unstructured":"Sch\u00fctze C et al (2015) Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration. Am J Ophthalmol 159(6):1100-1114.e1","journal-title":"Am J Ophthalmol"},{"key":"6790_CR52","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bjo-2023-324713","volume":"108","author":"P Forte","year":"2024","unstructured":"Forte P et al (2024) Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation. Br J Ophthalmol 108:1240\u20131248","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"6790_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/IAE.0000000000001279","volume":"37","author":"R Dolz-Marco","year":"2017","unstructured":"Dolz-Marco R et al (2017) Regression of type 2 neovascularization into a type 1 pattern after intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Retina 37(2):222\u2013233","journal-title":"Retina"},{"issue":"5","key":"6790_CR54","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/IAE.0000000000002552","volume":"40","author":"JB Kumar","year":"2020","unstructured":"Kumar JB et al (2020) Correlation of subretinal hyperreflective material morphology and visual acuity in neovascular age-related macular degeneration. Retina 40(5):845\u2013856","journal-title":"Retina"},{"key":"6790_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2023.12.011","volume":"261","author":"KYC Teo","year":"2024","unstructured":"Teo KYC et al (2024) Features associated with vision in eyes with subfoveal fibrosis from neovascular age-related macular degeneration. Am J Ophthalmol 261:121\u2013131","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"6790_CR56","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG et al (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology 123(8):1751\u20131761","journal-title":"Ophthalmology"},{"issue":"6","key":"6790_CR57","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ophtha.2017.12.026","volume":"125","author":"SVR Sadda","year":"2018","unstructured":"Sadda SVR et al (2018) Macular atrophy in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 125(6):878\u2013886","journal-title":"Ophthalmology"},{"issue":"2","key":"6790_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jamaophthalmol.2015.4948","volume":"134","author":"SM Waldstein","year":"2016","unstructured":"Waldstein SM et al (2016) Correlation of 3-dimensionally quantified intraretinal and subretinal fluid with visual acuity in neovascular age-related macular degeneration. JAMA Ophthalmol 134(2):182\u2013190","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"6790_CR59","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1111\/aos.14905","volume":"100","author":"S Llorente-Gonz\u00e1lez","year":"2022","unstructured":"Llorente-Gonz\u00e1lez S et al (2022) The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world. Acta Ophthalmol 100(2):e521\u2013e531","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"6790_CR60","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1038\/s41433-020-01354-4","volume":"35","author":"U Chakravarthy","year":"2021","unstructured":"Chakravarthy U et al (2021) Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye 35(11):2983\u20132990","journal-title":"Eye"},{"issue":"10","key":"6790_CR61","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","volume":"138","author":"RN Evans","year":"2020","unstructured":"Evans RN et al (2020) Associations of variation in retinal thickness with visual acuity and anatomic outcomes in eyes with neovascular age-related macular degeneration lesions treated with anti-vascular endothelial growth factor agents. JAMA Ophthalmol 138(10):1043\u20131051","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"6790_CR62","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/IAE.0000000000000609","volume":"35","author":"C Iaculli","year":"2015","unstructured":"Iaculli C et al (2015) Outer retinal tubulation. Retina 35(10):1979\u20131984","journal-title":"Retina"},{"issue":"12","key":"6790_CR63","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","volume":"127","author":"SAMD Zweifel","year":"2009","unstructured":"Zweifel SAMD et al (2009) Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 127(12):1596\u20131602","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"6790_CR64","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/IAE.0000000000000471","volume":"35","author":"KB Schaal","year":"2015","unstructured":"Schaal KB et al (2015) Outer retinal tubulation in advanced age-related macular degeneration optical coherence tomographic findings correspond to histology. Retina 35(7):1339\u20131350","journal-title":"Retina"},{"issue":"1","key":"6790_CR65","doi-asserted-by":"publisher","first-page":"14735","DOI":"10.1038\/s41598-021-94310-5","volume":"11","author":"A Arrigo","year":"2021","unstructured":"Arrigo A et al (2021) Outer retinal tubulation formation and clinical course of advanced age-related macular degeneration. Sci Rep 11(1):14735\u201314735","journal-title":"Sci Rep"},{"issue":"12","key":"6790_CR66","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.ophtha.2014.06.013","volume":"121","author":"JY Lee","year":"2014","unstructured":"Lee JY et al (2014) Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology 121(12):2423\u20132431","journal-title":"Ophthalmology"},{"issue":"9","key":"6790_CR67","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1097\/IAE.0000000000003127","volume":"41","author":"E Janse van Rensburg","year":"2021","unstructured":"Janse van Rensburg E et al (2021) Outer retinal tubulation may result from fibrosed type 2 neovascularization: Clinical Observations and Model of Pathogenesis. Retina 41(9):1930\u20131939","journal-title":"Retina"},{"issue":"3","key":"6790_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000346854","volume":"229","author":"F Faria-Correia","year":"2013","unstructured":"Faria-Correia F et al (2013) Characterization of neovascular age-related macular degeneration patients with outer retinal tubulations. Ophthalmologica 229(3):147\u2013151","journal-title":"Ophthalmologica"},{"issue":"12","key":"6790_CR69","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/s41433-020-0803-6","volume":"34","author":"KX Cheong","year":"2020","unstructured":"Cheong KX et al (2020) The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Eye 34(12):2257\u20132263","journal-title":"Eye"},{"issue":"9","key":"6790_CR70","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/eye.2011.146","volume":"25","author":"M Gutfleisch","year":"2011","unstructured":"Gutfleisch M et al (2011) Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye 25(9):1181\u20131186","journal-title":"Eye"},{"issue":"4","key":"6790_CR71","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.survophthal.2017.03.004","volume":"62","author":"MG Ersoz","year":"2017","unstructured":"Ersoz MG et al (2017) Retinal pigment epithelium tears: classification, pathogenesis, predictors, and management. Surv Ophthalmol 62(4):493\u2013505","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"6790_CR72","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/eye.1988.22","volume":"2","author":"EL Chuang","year":"1988","unstructured":"Chuang EL, Bird AC (1988) Repair after tears of the retinal pigment epithelium. Eye 2(1):106\u2013113","journal-title":"Eye"},{"issue":"6","key":"6790_CR73","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1167\/iovs.15-16735","volume":"56","author":"F Coscas","year":"2015","unstructured":"Coscas F et al (2015) Restoration of outer retinal layers after aflibercept therapy in exudative AMD: prognostic value. Invest Ophthalmol Vis Sci 56(6):4129\u20134134","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"6790_CR74","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/bjo.2008.151977","volume":"93","author":"K Sayanagi","year":"2009","unstructured":"Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93(5):622\u2013626","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"6790_CR75","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.oret.2018.11.011","volume":"3","author":"CA Toth","year":"2019","unstructured":"Toth CA et al (2019) Distribution of OCT features within areas of macular atrophy or scar after 2 years of anti-VEGF treatment for neovascular AMD in CATT. Ophthalmol Retina 3(4):316\u2013325","journal-title":"Ophthalmol Retina"},{"key":"6790_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF et al (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1\u201355","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"6790_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjophthalmol-2019-315763","volume":"105","author":"H Xiao","year":"2021","unstructured":"Xiao H et al (2021) Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation. Br J Ophthalmol 105(1):103\u2013108","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"6790_CR78","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/ceo.13367","volume":"47","author":"K Balaskas","year":"2019","unstructured":"Balaskas K et al (2019) Swept-source optical coherence tomography angiography features of sub-retinal fibrosis in neovascular age-related macular degeneration. Clin Experiment Ophthalmol 47(2):233\u2013239","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"6790_CR79","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bjophthalmol-2016-308815","volume":"101","author":"N Phasukkijwatana","year":"2017","unstructured":"Phasukkijwatana N et al (2017) Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy. Br J Ophthalmol 101(5):597\u2013602","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"6790_CR80","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1364\/BOE.8.001838","volume":"8","author":"CK Hitzenberger","year":"2017","unstructured":"Hitzenberger CK, Boer JFd, Yasuno Y (2017) Polarization sensitive optical coherence tomography - a review [Invited]. Biomed Opt Express 8(3):1838\u20131873","journal-title":"Biomed Opt Express"},{"issue":"7","key":"6790_CR81","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1364\/BOE.426650","volume":"12","author":"AR Motschi","year":"2021","unstructured":"Motschi AR et al (2021) Identification and quantification of fibrotic areas in the human retina using polarization-sensitive OCT. Biomed Opt Express 12(7):4380\u20134380","journal-title":"Biomed Opt Express"},{"issue":"6","key":"6790_CR82","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.preteyeres.2011.06.003","volume":"30","author":"M Pircher","year":"2011","unstructured":"Pircher M, Hitzenberger CK, Schmidt-Erfurth U (2011) Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res 30(6):431\u2013451","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"6790_CR83","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1167\/iovs.15-18694","volume":"57","author":"P Roberts","year":"2016","unstructured":"Roberts P et al (2016) Automated identification and quantification of subretinal fibrosis in neovascular age-related macular degeneration using polarization-sensitive OCT. Invest Ophthalmol Vis Sci 57(4):1699\u20131705","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"6790_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.9.4.13","volume":"9","author":"MGO Gr\u00e4fe","year":"2020","unstructured":"Gr\u00e4fe MGO et al (2020) Subretinal fibrosis detection using polarization sensitive optical coherence tomography. Transl Vision Sci Technol 9(4):13\u201313","journal-title":"Transl Vision Sci Technol"},{"key":"6790_CR85","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/jcm13041074","volume":"13","author":"M Schranz","year":"2024","unstructured":"Schranz M et al (2024) Structure-function correlation of retinal fibrosis in eyes with neovascular age-related macular degeneration. J Clin Med 13:1074. https:\/\/doi.org\/10.3390\/jcm13041074","journal-title":"J Clin Med"},{"issue":"1","key":"6790_CR86","doi-asserted-by":"publisher","first-page":"19545","DOI":"10.1038\/s41598-023-46626-7","volume":"13","author":"O Leingang","year":"2023","unstructured":"Leingang O et al (2023) Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5). Sci Rep 13(1):19545","journal-title":"Sci Rep"},{"key":"6790_CR87","first-page":"251584142210833","volume":"14","author":"GS Reiter","year":"2022","unstructured":"Reiter GS, Schmidt-Erfurth U (2022) Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy. Ther Adv Ophthalmol 14:251584142210833\u2013251584142210833","journal-title":"Ther Adv Ophthalmol"},{"issue":"10","key":"6790_CR88","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1016\/S2589-7500(21)00134-5","volume":"3","author":"G Zhang","year":"2021","unstructured":"Zhang G et al (2021) Clinically relevant deep learning for detection and quantification of geographic atrophy from optical coherence tomography: a model development and external validation study. Lancet Digit Health 3(10):e665\u2013e675","journal-title":"Lancet Digit Health"},{"issue":"9","key":"6790_CR89","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J et al (2018) Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med 24(9):1342\u20131350","journal-title":"Nat Med"},{"issue":"6","key":"6790_CR90","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-020-0867-7","volume":"26","author":"J Yim","year":"2020","unstructured":"Yim J et al (2020) Predicting conversion to wet age-related macular degeneration using deep learning. Nat Med 26(6):892\u2013899","journal-title":"Nat Med"},{"issue":"5","key":"6790_CR91","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","volume":"128","author":"G Moraes","year":"2021","unstructured":"Moraes G et al (2021) Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning. Ophthalmology 128(5):693\u2013705","journal-title":"Ophthalmology"},{"issue":"1","key":"6790_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-19413-z","volume":"12","author":"K Balaskas","year":"2022","unstructured":"Balaskas K et al (2022) Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning. Sci Rep 12(1):1\u201311","journal-title":"Sci Rep"},{"issue":"7","key":"6790_CR93","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/IAE.0000000000000483","volume":"35","author":"CA Toth","year":"2015","unstructured":"Toth CA et al (2015) Identification of fluid on optical coherence tomography by treating ophthalmologists versus a reading center in the comparison of age-related macular degeneration treatments trials. Retina 35(7):1303\u20131314","journal-title":"Retina"},{"key":"6790_CR94","first-page":"915","volume":"159","author":"J de la Fuente","year":"2023","unstructured":"de la Fuente J et al (2023) Suitability of machine learning for atrophy and fibrosis development in neovascular age-related macular degeneration. Acta Ophthalmol 159:915","journal-title":"Acta Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06790-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:44:50Z","timestamp":1757151890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06790-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6790"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06790-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Nikolas Pontikos is the non-salaried co-founder and director of Phenopolis Ltd.\u00a0Ismail Moghul has equity in READ AI Konstantinos Balaskas has\u00a0equity in READ AI received speaker fees from Novartis, Bayer, Alimera, Allergan, Roche, and Heidelberg; meeting or travel fees from Novartis, Bayer and Boehringer-Ingelheim; compensation for being on an advisory board from Novartis, Bayer and Apellis; consulting fees from Novartis, Roche and Google; and research support from Apellis, Novartis, and Bayer. All other authors declare no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with humans or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}